Koelis

What Koelis does

Koelis is a privately held French medical technology company founded in 2006 in Meylan (near Grenoble), France, by Antoine Leroy (CEO) and Patrick Henri. The company specializes in MRI/Ultrasound fusion biopsy systems for prostate cancer diagnosis and treatment, serving urologists, radiologists, and hospitals across more than 50 countries. Its flagship product, KOELIS Trinity, is a mobile fusion imaging platform that combines proprietary 3D ultrasound technology with patented Organ-Based Tracking Fusion (OBT Fusion), which tracks the prostate itself rather than the ultrasound probe to compensate for organ deformation and patient movement during biopsy procedures.

The company's technology platform extends across the full clinical workflow from diagnosis to treatment. Core technologies include OBT Fusion for millimeter-precision needle guidance, 2nd Look Fusion for superimposition of prior biopsy sessions to support active surveillance, and ProMap Smart, an AI-assisted auto-contouring software trained on 8,000+ expert-annotated images that achieves 98% prostate segmentation accuracy in under 5 seconds. Supporting products include ProMap Contour and ProMap Lite for MRI annotation workflows, transperineal and transrectal needle guides (consumables), the Steady Pro probe holder, and a range of 3D ultrasound probes. The VIOLETTE clinical trial has demonstrated 81% of patients remaining free from clinically significant cancer at 12 months following Targeted Microwave Ablation focal therapy.

Koelis operates a direct enterprise sales model through wholly-owned subsidiaries in France (HQ), the United States (2015), Singapore (2019), and Germany (2022), supported by territory managers and clinical application specialists. Revenue derives from capital equipment sales (KOELIS Trinity systems, ultrasound probes), recurring consumables (single-use needle guides), software licenses and AI modules (ProMap family), and annual maintenance contracts. To date, approximately 300,000 patients have been treated using Koelis technology, validated by 80+ peer-reviewed clinical publications. The company has raised funding from Medevice Capital (2011) and InnovaHealth Partners (2019 equity round, 2022 Series B), with no public market listing.

Name

Koelis

Legal name

Koelis SAS

Website

https://koelis.com

Company type

Private

Founded year

2006

Operating status

Operating

Headcount range

11–50 employees

Short description

Koelis is a French medical technology company that develops MRI/Ultrasound fusion biopsy systems with proprietary Organ-Based Tracking for prostate cancer diagnosis and focal therapy, serving urologists and hospitals across 50+ countries through direct enterprise sales.

Ownership category

akta.pro rank

Product category

Medical Imaging Equipment - MRI/Ultrasound Fusion Biopsy Systems for Prostate Cancer

NAICS

Electromedical and Electrotherapeutic Apparatus Manufacturing (334510), Surgical and Medical Instrument Manufacturing (339112), Surgical Appliance and Supplies Manufacturing (339113)

SIC

Surgical & Medical Instruments & Apparatus (3841), Electromedical & Electrotherapeutic Apparatus (3845)

akta.pro primary industry

Interventional Radiology & Image-Guided Therapy Systems (HLAHABAG)

akta.pro secondary industries

Intraoperative Imaging & Guidance (C-arms, O-arm, IOUS, fluorescence) (HLAHADAH), Portable, Mobile & Point-of-Care Imaging Systems (HLAHABAL), Surgical Robotics & Computer-Assisted Surgery Platforms (HLAHADAF)

Keywords

• Fusion biopsy systems
• Prostate imaging devices
• MRI ultrasound fusion
• Urology medical equipment
• Focal therapy technology

Headquarters

HQ city

Meylan

HQ country

France

HQ region

Europe

Offices4 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Personnel, Technology or R&D, Operations, Marketing or Sales, Supply Chain, Infrastructure

Revenue model

1. Medical Device Hardware Sales: Sale of KOELIS Trinity fusion biopsy systems, 3D ultrasound probes (transperineal and transrectal), needle guides, and accessories including Steady Pro probe holder. The system is a mobile, integrated ultrasound platform requiring capital equipment purchase by hospitals.
2. Software Licenses and Subscriptions: ProMap software products (Smart, Contour, Lite) provide AI-assisted contouring and MRI annotation capabilities. Software may include annual licenses with updates and support as part of the offering.
3. Consumables: Single-use needle guides (transperineal and transrectal) generate recurring consumable revenue from procedure volume at customer sites.

Pricing tiers

Go-to-market motion1 record

Distribution channels3 records

Marketing channels7 records

Core offering

Koelis designs, manufactures, and sells the KOELIS Trinity, a mobile MRI/ultrasound fusion imaging platform used by urologists to perform targeted prostate biopsies and focal therapy procedures. The system combines proprietary Organ-Based Tracking (OBT) Fusion technology with robotic 3D ultrasound and is sold alongside needle guides, ultrasound probes, and the AI-assisted ProMap software family.

Product overview

Koelis offers a unified platform-plus-modules architecture centered on the KOELIS Trinity fusion biopsy system. The core platform combines 3D ultrasound with MRI-US elastic fusion and proprietary OBT Fusion organ tracking technology. Supporting modules include ProMap Smart (AI-assisted auto-contouring), ProMap Contour (third-party AI MRI compatibility), and ProMap Lite (radiology software for pre-fusion MRI preparation). Accessories include transperineal/transrectal needle guides, the Steady Pro probe holder, and a comprehensive range of 3D ultrasound probes (transperineal, transrectal, linear, and abdominal). Key technologies include OBT Fusion for organ-based tracking, 2nd Look Fusion for repeat biopsy procedures, and 3D Ultrasound with robotic beam technology.

Differentiator

Problem solved

Functional benefit

Brands

• ProMap Smart: AI-powered prostate segmentation software that achieves 98% accuracy in automating prostate contouring on MRI scans in under five seconds
• ProMap Contour
• ProMap Lite
• KOELIS Trinity
• OBT Fusion
• 2nd Look Fusion
• 3D Ultrasound
• Steady Pro
• TMA (Targeted Microwave Ablation)

Products and services

• KOELIS Trinity Fully integrated mobile MRI/ultrasound fusion imaging platform that combines 3D ultrasound with OBT Fusion organ-based tracking to provide accurate needle guidance for prostate biopsies and focal therapy procedures, sold as capital equipment to hospitals and cancer centers.
• ProMap Smart AI-assisted auto-contouring software add-on for the KOELIS Trinity that automates prostate segmentation on MRI and ultrasound images, enabling standardized and faster fusion biopsy workflows for radiologists and urologists.
• ProMap Contour Software module that makes the KOELIS Trinity compatible with third-party AI MRI formats, allowing radiologists to perform MRI contouring on dedicated software and import annotated images into the Trinity in three clicks.
• ProMap Lite Radiology software for pre-fusion MRI biopsy preparation, providing three-point prostate contouring with a semi-automated algorithm, 3D lesion contouring, and PI-RADS scoring for accurate biopsies.
• TP & TR Range Needle Guides Single-use and reusable needle guides for transperineal and transrectal prostate biopsy approaches, including Perine Mini Grid, Perine Full Grid, Perine Nail, and disposable/reusable transrectal guides designed for use with the KOELIS Trinity.
• Steady Pro Mechanical prostate probe holder that assists physicians in performing optimal targeted biopsies and treatments by reducing movement restrictions and helping maintain convenient probe positions for both transrectal and transperineal approaches.
• Ultrasound Probes Comprehensive range of 3D ultrasound probes compatible with KOELIS Trinity, including transperineal side-fire (K3DEL00 / K3DEL00-2, 4-9 MHz), transrectal end-fire (K3DEC00-2, 4-9 MHz), linear (K2DLN00, 7-15 MHz), and abdominal (K2DAB00, 2-5 MHz) probes.

Quantifiable outcome

• 98% AI contouring accuracy achieved in under 5 seconds with ProMap Smart
• +5 more outcomes

Named customers7 records

Segments3 records

Ideal customer profiles1 record

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration3 records

AI capability2 records

Feature6 records

Partnerships

Two partnerships are on record, tiered core.

• DeepHealthcoreTechnology or Integration · 11 October 2024Koelis partnered with DeepHealth to integrate DeepHealth's AI-powered Prostate software with the Koelis Trinity 3D Ultrasound Platform. The integration streamlines prostate MRI reading and lesion detection, allowing radiologists to import AI-contoured sequences into Koelis Trinity for improved workflow efficiency in fusion biopsy procedures.
• Bot ImagecoreTechnology or IntegrationKoelis Trinity is fully integrated with Bot Image AI software for automatic MRI segmentation and lesion detection. Bot Image's Prostate software (North America's first automatic MRI segmentation and lesion detection software) enhances procedural efficiency and workflow for Koelis users.

Scale indicators8 records

Recent moves9 records

Expansion highlights6 records

Direct peers

• Focal Healthcare: Direct competitor offering the Fusion Bx and Fusion MR systems for MRI-ultrasound fusion prostate biopsy, with similar target customers (urology practices and hospitals) and overlapping technology approach.

Broad incumbents

• Philips (UroNav / Eigen): Philips acquired Eigen and markets UroNav, a leading MRI-US fusion biopsy system, alongside a broad imaging portfolio. Overlaps directly with Koelis in fusion-guided prostate biopsy but competes across many other modalities.
• GE HealthCare (BK Medical): GE HealthCare, via BK Medical, offers fusion biopsy ultrasound solutions integrated with its broader imaging ecosystem. Competes with Koelis in fusion-guided prostate biopsy while serving many other imaging segments.
• FUJIFILM Healthcare (Hitachi):

Market position

Strengths4 records

Weaknesses4 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• YouTubepodcast.ausha.co/prostate-talk
• LinkedInlinkedin.com/company/koelis

Compliance1 record

Revenue estimate

Valuation estimate

Number of profiles

Profiles3 records

Subsidiaries3 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Koelis